PRESTIGE® 5 + WNV
(EEE, WEE, EIV, EHV-1, EHV-4, WNV killed, Tetanus Toxoid)
PRESTIGE® 5 + WNV
PRESTIGE flu-containing equine vaccines provide the most updated flu strains available.
- Multiple antigen combination reduces need for several injections
- Formulated to minimize reactions and maximize protection
- Available in 10-dose vials and 1 mL single-dose prefilled syringes
- Tetanus, WNV, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
- Provides 6 months of protection against EIV
- A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus – flavivirus chimera and tetanus toxoid
- Advanced filtration process through the Antigen Purification System (APS™)
- Exceptional safety profile with the exclusive Havlogen® Adjuvant
This product has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV), equine herpesvirus type 1 (EHV-1), equine herpesvirus type 4 (EHV-4), tetanus and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for Eastern and Western encephalomyelitis viruses, EHV-1, EHV-4, tetanus and West Nile Virus has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to be effective against virus shedding of EIV, EHV-1 and EHV-4, and encephalitis and viremia caused by West Nile Virus.
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 – 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.
Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY
Learn more about the updated line of PRESTIGE vaccines.
A guide to the entire equine product line from Merck Animal Health.
Understanding genetic characterization of recent equine influenza outbreaks to assess relevance of vaccine influenza strains.
Customize your West Nile protection to the patient, with high degrees of safety for the horse and convenience for you.
Learn more about PRESTIGE flu-containing vaccines.
No items to show.